Evidence map›Paper›PMID 23557705›Full record

ArticleDiabetes2013

Identification of a loss-of-function mutation in Ube2l6 associated with obesity resistance.

Genevieve Marcelin, Shun-Mei Liu, Gary J Schwartz, Streamson C Chua

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Combined pharmacological targeting of CD9Cell reports. Medicine · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The genetic basis of obesity-associated type 2 diabetes (diabesity) in polygenic mouse models.Mammalian genome : official journal of the International Mammalian Genome Society · 2014
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Genevieve MarcelinDepartment of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
Shun-Mei Liu
Gary J Schwartz
Streamson C Chua
Albert Einstein College of Medicine · US

Funding

RESEARCH TRAININGP30DK026687 · NIDDK · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI Anthony W Ferrante, DYMPNA GALLAGHER · 1986 to 2026
$33.0M
Stable Isotope and Metabolomics CoreP60DK020541 · NIDDK · YESHIVA UNIVERSITY · PI FLEISCHER, NORMAN S. · 1986 to 2014
$29.8M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
PROJECT 4 - Antagonistic Actions of Melanocortins and Leptin on Reproductive CompU54HD058155 · NICHD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI POLLARD, JEFFREY W. · 2009 to 2013
$6.8M
LEPTIN RECEPTOR AND THE OBESITY/DIABETES SYNDROMER01DK057621 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHUA, STREAMSON C · 2000 to 2010
$4.4M
NICHD NIH HHS HD058155NICHD NIH HHS U54 HD058155NIDDK NIH HHS DK020541NIDDK NIH HHS P01DK26687NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P30 DK026687NIDDK NIH HHS P60 DK020541NIDDK NIH HHS R01 DK057621NIDDK NIH HHS R01DK057621
6 · The paper itself

Abstract

We previously mapped a locus on BALB/c chromosome 2 associated with protection from leptin-deficiency-induced obesity. Here, we generated the corresponding congenic mouse strain by introgression of a segment of C57BL/6J chromosome 2 to the BALB/c background to confirm the genotype-phenotype associations. We found that the BALB/c alleles decreased fat mass expansion by limiting adipocyte hyperplasia and adipocyte hypertrophy. This was concomitant to an increase in adipocyte triglyceride lipase (ATGL)-mediated triglyceride breakdown and prolongation of ATGL half-life in adipose tissue. In addition, BALB/c alleles on chromosome 2 exerted a cell-autonomous role in restraining the adipogenic potential of preadipocytes. Within a 9.8-Mb critical interval, we identified a nonsynonymous coding single nucleotide polymorphism in the gene coding for the ubiquitin-conjugating enzyme E2L6 (Ube2l6, also known as Ubch8) and showed that the BALB/c allele of Ube2l6 is a hypomorph leading to the lack of UBE2L6 protein expression. Ube2l6 knockdown in 3T3-L1 adipocytes repressed adipogenesis. Thus, altered adipogenic potential caused by Ube2l6 knockdown is likely critically involved in BALB/c obesity resistance by inhibiting adipogenesis and reducing adipocyte numbers. Overall, we have identified a loss-of-function mutation in Ube2l6 that contributes to the chromosome 2 obesity quantitative trait locus.

Indexed as

3T3-L1 CellsAdipocytesAdipogenesisAdipose TissueAllelesAnimalsBlood GlucoseCell DifferentiationEnergy MetabolismMiceMice, Inbred BALB CMutationObesityQuantitative Trait LociUbiquitin-Conjugating EnzymesBlood GlucoseUbiquitin-Conjugating Enzymes

Identifiers

PMID23557705
PMCPMC3717837
OpenAlexW2167486919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.